Propionyl-HIST1H4A (K16) Antibody

Shipped with Ice Packs
In Stock

Description

Target Definition and Biological Context

Propionyl-HIST1H4A (K16) refers to a covalent modification of histone H4, where a propionyl group (-COCH₂CH₃) is added to lysine 16. Histone H4 (encoded by HIST1H4A and related isoforms) is a core component of nucleosomes, which compact DNA into chromatin . Propionylation at K16 is part of the "histone code" that regulates DNA accessibility for transcription, replication, and repair .

Key features of histone H4 and K16 modifications:

  • Molecular weight: ~11 kDa

  • Associated processes: Chromatin remodeling, transcriptional activation, DNA damage response

  • Competing modifications: Acetylation, butyrylation, and crotonylation at K16

Research Applications and Validation Data

The Propionyl-HIST1H4A (K16) Antibody has been validated for multiple experimental workflows:

ApplicationDilution RangeSupported AssaysKey References
Chromatin Analysis1:100–1:1,000ChIP, ChIP-seq
Protein Detection1:100–1:1,000Western blot, Immunofluorescence
Quantification1:2,000–1:10,000ELISA

Key validation data:

  • Western blot: Single band at 11 kDa in HeLa cell lysates, with enhanced signal after trichostatin A (TSA) treatment .

  • Immunofluorescence: Nuclear localization in human cell lines (e.g., HeLa), intensified in TSA-treated samples .

  • Species reactivity: Human-specific .

Antibody Characterization and Specificity

The antibody was raised against a synthetic peptide containing propionylated K16, ensuring specificity for this modification . Cross-reactivity tests confirm no binding to:

  • Unmodified histone H4

  • Acetylated, butyrylated, or crotonylated H4K16

Comparative analysis of H4K16-targeting antibodies:

ModificationAntibody CatalogSupplierApplications
Propionyl-K16PACO59597Assay Genie ChIP, WB, ELISA
Acetyl-K16ab109463Abcam IF, WB, IHC
Butyryl-K16CAC11483Biomatik ChIP, WB

Functional Insights from Research

  • Chromatin dynamics: Propionylation at H4K16 correlates with transcriptional activation, similar to acetylation, but with distinct metabolic origins .

  • Disease relevance: Aberrant histone propionylation is implicated in cancer and metabolic disorders, though mechanistic studies remain ongoing .

  • Technical advantage: Unlike acetylation-focused antibodies (e.g., ab109463 ), this tool specifically decouples propionyl-dependent epigenetic effects .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Typically, we can ship products within 1-3 business days after receiving your order. Delivery times may vary depending on the purchasing method or location. Please consult your local distributor for specific delivery timeframes.
Synonyms
dJ160A22.1 antibody; dJ160A22.2 antibody; dJ221C16.1 antibody; dJ221C16.9 antibody; FO108 antibody; H4 antibody; H4.k antibody; H4/a antibody; H4/b antibody; H4/c antibody; H4/d antibody; H4/e antibody; H4/g antibody; H4/h antibody; H4/I antibody; H4/j antibody; H4/k antibody; H4/m antibody; H4/n antibody; H4/p antibody; H4_HUMAN antibody; H4F2 antibody; H4F2iii antibody; H4F2iv antibody; H4FA antibody; H4FB antibody; H4FC antibody; H4FD antibody; H4FE antibody; H4FG antibody; H4FH antibody; H4FI antibody; H4FJ antibody; H4FK antibody; H4FM antibody; H4FN antibody; H4M antibody; HIST1H4A antibody; HIST1H4B antibody; HIST1H4C antibody; HIST1H4D antibody; HIST1H4E antibody; HIST1H4F antibody; HIST1H4H antibody; HIST1H4I antibody; HIST1H4J antibody; HIST1H4K antibody; HIST1H4L antibody; HIST2H4 antibody; HIST2H4A antibody; Hist4h4 antibody; Histone 1 H4a antibody; Histone 1 H4b antibody; Histone 1 H4c antibody; Histone 1 H4d antibody; Histone 1 H4e antibody; Histone 1 H4f antibody; Histone 1 H4h antibody; Histone 1 H4i antibody; Histone 1 H4j antibody; Histone 1 H4k antibody; Histone 1 H4l antibody; Histone 2 H4a antibody; histone 4 H4 antibody; Histone H4 antibody; MGC24116 antibody
Target Names
HIST1H4A
Uniprot No.

Target Background

Function
Histone H4 is a core component of the nucleosome, which is the fundamental unit of chromatin. Nucleosomes wrap and compact DNA, thereby limiting accessibility to cellular machinery that requires DNA as a template. Consequently, histones play a crucial role in regulating transcription, DNA repair, DNA replication, and maintaining chromosomal stability. DNA accessibility is regulated through a complex set of post-translational modifications of histones, also known as the histone code, and nucleosome remodeling.
Gene References Into Functions
  1. Research indicates that PP32 and SET/TAF-Ibeta proteins inhibit HAT1-mediated H4 acetylation. PMID: 28977641
  2. Studies suggest that post-translational modifications of histones, specifically trimethylation of lysine 36 in H3 (H3K36me3) and acetylation of lysine 16 in H4 (H4K16ac), are involved in DNA damage repair. H3K36me3 stimulates H4K16ac upon DNA double-strand break. SETD2, LEDGF, and KAT5 are essential for these epigenetic changes. (SETD2 = SET domain containing 2; LEDGF = lens epithelium-derived growth factor; KAT5 = lysine acetyltransferase 5) PMID: 28546430
  3. Data demonstrate that Omomyc protein co-localizes with proto-oncogene protein c-myc (c-Myc), protein arginine methyltransferase 5 (PRMT5), and histone H4 H4R3me2s-enriched chromatin domains. PMID: 26563484
  4. H4K12ac is regulated by estrogen receptor-alpha and is associated with BRD4 function and inducible transcription PMID: 25788266
  5. Systemic lupus erythematosus appears to be associated with an imbalance in histone acetyltransferases and histone deacetylase enzymes, favoring pathological H4 acetylation. PMID: 25611806
  6. Sumoylated human histone H4 prevents chromatin compaction by inhibiting long-range internucleosomal interactions. PMID: 25294883
  7. Acetylation at lysine 5 of histone H4 is associated with lytic gene promoters during reactivation of Kaposi's sarcoma-associated herpesvirus. PMID: 25283865
  8. An increase in histone H4 acetylation caused by hypoxia in human neuroblastoma cell lines corresponds to increased levels of N-myc transcription factor in these cells. PMID: 24481548
  9. Data indicate that G1-phase histone assembly is restricted to CENP-A and H4. PMID: 23363600
  10. This study focused on the distribution of a specific histone modification, namely H4K12ac, in human sperm and characterized its specific enrichment sites in promoters throughout the whole human genome. PMID: 22894908
  11. SRP68/72 heterodimers act as major nuclear proteins whose binding of the histone H4 tail is inhibited by H4R3 methylation. PMID: 23048028
  12. TNF-alpha inhibition of AQP5 expression in human salivary gland acinar cells is attributed to the epigenetic mechanism by suppression of acetylation of histone H4. PMID: 21973049
  13. Research suggests that global histone H3 and H4 modification patterns are potential markers of tumor recurrence and disease-free survival in non-small cell lung cancer PMID: 22360506
  14. HAT1 differentially impacts nucleosome assembly of H3.1-H4 and H3.3-H4. PMID: 22228774
  15. Phosphorylation of histone H4 Ser 47 catalyzed by the PAK2 kinase promotes nucleosome assembly of H3.3-H4 and inhibits nucleosome assembly of H3.1-H4 by increasing the binding affinity of HIRA to H3.3-H4 and reducing association of CAF-1 with H3.1-H4 PMID: 21724829
  16. The imatinib-induced hemoglobinization and erythroid differentiation in K562 cells are associated with global histone H4 PMID: 20949922
  17. Findings reveal the molecular mechanisms whereby the DNA sequences within specific gene bodies are sufficient to nucleate the monomethylation of histone H4 lysine 200 which, in turn, reduces gene expression by half. PMID: 20512922
  18. Downregulated by zinc and upregulated by docosahexaenoate in a neuroblastoma cell line. PMID: 19747413
  19. Low levels of histone acetylation are associated with the development and progression of gastric carcinomas, possibly through alteration of gene expression PMID: 12385581
  20. Overexpression of MTA1 protein and acetylation level of histone H4 protein are closely related PMID: 15095300
  21. Peptidylarginine deiminase 4 regulates histone Arg methylation by converting methyl-Arg to citrulline and releasing methylamine. Data suggest that PAD4 mediates gene expression by regulating Arg methylation and citrullination in histones PMID: 15345777
  22. Lack of biotinylation of K12 in histone H4 is an early signaling event in response to double-strand breaks PMID: 16177192
  23. Incorporation of acetylated histone H4-K16 into nucleosomal arrays inhibits the formation of compact 30-nanometer-like fibers and impedes the ability of chromatin to form cross-fiber interactions PMID: 16469925
  24. Apoptosis is associated with global DNA hypomethylation and histone deacetylation events in leukemia cells. PMID: 16531610
  25. BTG2 contributes to retinoic acid activity by favoring differentiation through a gene-specific modification of histone H4 arginine methylation and acetylation levels. PMID: 16782888
  26. Relationship between histone H4 modification, epigenetic regulation of BDNF gene expression, and long-term memory for extinction of conditioned fear. PMID: 17522015
  27. The H4 tail and its acetylation have novel roles in mediating recruitment of multiple regulatory factors that can change chromatin states for transcription regulation PMID: 17548343
  28. Brd2 bromodomain 2 is monomeric in solution and dynamically interacts with H4-AcK12; additional secondary elements in the long ZA loop may be a common characteristic of BET bromodomains. PMID: 17848202
  29. Spermatids Hypac-H4 impairment in mixed atrophy did not deteriorate further by AZFc region deletion. PMID: 18001726
  30. The SET8 and PCNA interaction couples H4-K20 methylation with DNA replication PMID: 18319261
  31. H4K20 monomethylation and PR-SET7 are important for L3MBTL1 function PMID: 18408754
  32. High expression of acetylated H4 is more common in aggressive than indolent cutaneous T-cell lymphoma. PMID: 18671804
  33. Findings indicate an important role of histone H4 modifications in bronchial carcinogenesis PMID: 18974389
  34. Results indicate, by acetylation of histone H4 K16 during S-phase, early replicating chromatin domains acquire the H4K16ac-K20me2 epigenetic label that persists on the chromatin throughout mitosis and is deacetylated in early G1-phase of the next cell cycle PMID: 19348949
  35. Acetylated H4 is overexpressed in diffuse large B-cell lymphoma and peripheral T-cell lymphoma relative to normal lymphoid tissue. PMID: 19438744
  36. The release of histone H4 by holocrine secretion from the sebaceous gland may play a significant role in innate immunity. PMID: 19536143
  37. Histone modification, including PRC2-mediated repressive histone marker H3K27me3 and active histone marker acH4, may be involved in CD11b transcription during HL-60 leukemia cells reprogramming to terminal differentiation PMID: 19578722
  38. A role of Cdk7 in regulating elongation is further suggested by enhanced histone H4 acetylation and diminished histone H4 trimethylation on lysine 36, two marks of elongation within genes, when the kinase was inhibited. PMID: 19667075
  39. Data showed the dynamic fluctuation of histone H4 acetylation levels during mitosis, as well as acetylation changes in response to structurally distinct histone deacetylase inhibitors. PMID: 19805290
  40. Data directly implicate BBAP in the monoubiquitylation and additional posttranslational modification of histone H4 and an associated DNA damage response. PMID: 19818714

Show More

Hide All

Database Links

HGNC: 4781

OMIM: 142750

KEGG: hsa:121504

STRING: 9606.ENSP00000367034

UniGene: Hs.143080

Involvement In Disease
Chromosomal aberrations involving HISTONE H4 is a cause of B-cell non-Hodgkin lymphomas (B-cell NHL). Translocation t(3;6)(q27;p21), with BCL6.
Protein Families
Histone H4 family
Subcellular Location
Nucleus. Chromosome.

Q&A

What is the biological significance of histone H4 lysine 16 propionylation?

Propionylation at lysine 16 of histone H4 (HIST1H4A) represents one of several post-translational modifications that regulate chromatin structure and function. Like acetylation, propionylation neutralizes the positive charge of lysine residues, potentially weakening histone-DNA interactions and promoting a more open chromatin structure. Histone H4 is a core component of nucleosomes that wrap and compact DNA, limiting accessibility to cellular machinery required for processes such as transcription, DNA repair, and replication . The specific propionylation at K16 may serve as a distinct epigenetic mark that influences gene expression patterns differently from other modifications like acetylation .

How does propionylation at K16 differ functionally from acetylation at the same position?

While both propionylation and acetylation neutralize the positive charge of lysine residues, propionylation adds a slightly larger chemical group (propionyl vs. acetyl). This size difference may recruit distinct reader proteins and influence chromatin structure uniquely. Studies suggest propionylation may represent a metabolic-epigenetic link, as propionyl-CoA levels fluctuate with cellular metabolism . Compared to the well-studied H4K16 acetylation, which is known to be enriched around transcription start sites and plays critical roles in transcriptional activation , propionylation may provide complementary or distinct regulatory functions that are currently being characterized by researchers.

What are the common applications for Propionyl-HIST1H4A (K16) antibody?

Propionyl-HIST1H4A (K16) antibody can be utilized in multiple experimental approaches:

ApplicationTypical DilutionPurpose
Western Blot (WB)1:100-1:1000Detecting propionylated H4K16 in protein extracts
ELISA1:2000-1:10000Quantitative detection in solution
Chromatin Immunoprecipitation (ChIP)Optimized per protocolIdentifying genomic regions enriched for this modification
Immunofluorescence (IF)1:50-1:200Visualizing nuclear distribution patterns

These applications allow researchers to investigate the presence, distribution, and dynamics of H4K16 propionylation in various biological contexts . The antibody's specificity for propionylated versus acetylated K16 is critical for distinguishing between these related but distinct modifications.

How can I verify the specificity of Propionyl-HIST1H4A (K16) antibody against other similar histone modifications?

Verifying antibody specificity is crucial for accurate interpretation of histone modification studies. Recommended validation approaches include:

  • Peptide competition assays: Pre-incubating the antibody with propionylated H4K16 peptides should abolish signal, while pre-incubation with unmodified or differently modified peptides (e.g., acetylated H4K16) should not affect binding .

  • Peptide array analysis: Testing the antibody against a panel of differentially modified histone peptides can reveal cross-reactivity with similar modifications (e.g., acetylation, butyrylation at K16 or propionylation at other lysine residues) .

  • Immunoblotting with recombinant histones: Comparing signals between wild-type versus K16R mutant histones (where lysine is replaced with arginine, preventing modification) or using in vitro propionylated versus non-propionylated histones .

  • Mass spectrometry validation: Confirming that immunoprecipitated histones contain the expected propionyl-K16 modification and not other similar modifications .

This multi-pronged approach ensures that observed signals genuinely represent propionylated H4K16 rather than other modifications that might be structurally similar .

What factors affect the distribution of H4K16 propionylation across the genome compared to other H4 modifications?

The genomic distribution of H4K16 propionylation is influenced by several factors:

  • Metabolic state: Cellular levels of propionyl-CoA, derived from the metabolism of odd-chain fatty acids, certain amino acids, and cholesterol, may affect propionylation patterns .

  • Enzyme activity: The writers (propionyl-transferases) and erasers (depropionylases) regulate the dynamic addition and removal of propionyl groups. Many histone acetyltransferases (HATs) can also catalyze propionylation, though with different efficiencies .

  • Chromatin context: Pre-existing histone modifications may influence the accessibility of K16 to modifying enzymes. For example, an antibody against H4K5 acetylation (CMA405) reacts with K5ac only when neighboring K8 is unacetylated, suggesting that neighboring modifications influence antibody recognition and potentially enzyme activity .

  • Transcriptional state: Similar to H4K16 acetylation, which is enriched around transcription start sites, propionylation may show distinct correlations with active, poised, or silenced genes .

ChIP-seq experiments comparing the distribution of propionylated H4K16 with acetylated H4K16 and other modifications would provide valuable insights into their distinct genomic localizations and functional implications.

How do cell cycle dynamics affect H4K16 propionylation detection in experimental systems?

The detection of H4K16 propionylation may vary significantly throughout the cell cycle, which can impact experimental results:

  • Cell cycle phase distribution: Synchronizing cells or analyzing sorted populations based on cell cycle stage may reveal dynamic changes in propionylation patterns .

  • Newly synthesized histones: During S phase, newly synthesized histones are incorporated into chromatin with specific modification patterns. Similar to the diacetylation of newly assembled H4 at K5 and K12, propionylation may follow specific temporal patterns during chromatin assembly .

  • Mitotic compaction: During mitosis, global changes in histone modifications occur as chromatin condenses. Immunofluorescence experiments comparing interphase versus mitotic cells can reveal cell cycle-dependent changes in propionylation levels .

  • Experimental design considerations: When comparing propionylation levels between experimental conditions, controlling for cell cycle distribution differences is crucial to avoid misinterpreting changes due to cell cycle effects versus treatment effects .

Researchers should consider incorporating cell cycle markers or synchronization protocols when studying dynamic changes in H4K16 propionylation to account for these variations.

What are the optimal conditions for using Propionyl-HIST1H4A (K16) antibody in ChIP experiments?

Optimizing ChIP experiments with Propionyl-HIST1H4A (K16) antibody requires careful attention to several parameters:

  • Crosslinking: Standard 1% formaldehyde for 10 minutes at room temperature works for most histone modifications, but optimization may be needed depending on cell type .

  • Sonication: Aim for chromatin fragments of 200-500 bp for optimal resolution. Over-sonication may damage epitopes .

  • Antibody amount: Typically 2-5 μg per ChIP reaction, though titration experiments are recommended. Insufficient antibody leads to weak enrichment, while excess antibody may increase background .

  • Incubation conditions: Overnight incubation at 4°C with rotation typically yields best results .

  • Washing stringency: Balance between reducing background and maintaining specific interactions. Typically include low-salt, high-salt, LiCl, and TE washes .

  • Controls: Include input chromatin, IgG negative control, and ChIP with antibodies against well-characterized modifications (e.g., H3K4me3 at active promoters) as positive controls .

For ChIP-seq applications, library preparation should follow standard protocols, with sequencing depth of at least 20 million uniquely mapped reads per sample for adequate coverage of the genome.

How should I optimize Western blot protocols for detecting propionylated H4K16?

Western blot detection of propionylated H4K16 requires special considerations:

  • Sample preparation: Acid extraction of histones improves detection compared to whole cell lysates. A protocol using 0.2N HCl followed by TCA precipitation yields concentrated, enriched histone preparations .

  • Gel selection: 15-18% SDS-PAGE gels or specialized Triton-Acid-Urea gels provide better resolution of histone bands. Histone H4 resolves at approximately 11-12 kDa .

  • Transfer conditions: Use PVDF membrane and optimize transfer of small proteins (wet transfer with 20% methanol buffer at 30V overnight at 4°C works well) .

  • Blocking: 5% BSA in TBST is generally more effective than milk for phospho- and other modified histone epitopes .

  • Antibody dilution: Start with 1:1000 dilution for primary antibody incubation (overnight at 4°C), but optimize based on signal-to-noise ratio .

  • Detection: Enhanced chemiluminescence provides good sensitivity, but fluorescent secondary antibodies allow for multiplexing with other histone marks .

  • Controls: Include recombinant H4 proteins with defined modification states as positive and negative controls .

Troubleshooting tip: If signal is weak, treatment of cells with histone deacetylase inhibitors (e.g., sodium butyrate) prior to harvesting can increase global levels of histone acylations including propionylation, aiding in detection .

What are the critical factors to consider when interpreting immunofluorescence results with this antibody?

Interpreting immunofluorescence experiments using Propionyl-HIST1H4A (K16) antibody requires attention to several factors:

  • Fixation method: Paraformaldehyde (4%, 10 min) generally preserves histone modifications well. Methanol fixation may improve nuclear accessibility but can affect some epitopes .

  • Permeabilization: Adequate permeabilization (0.2% Triton X-100, 10 min) is essential for antibody access to nuclear epitopes .

  • Antigen retrieval: For FFPE tissues or challenging samples, heat-induced epitope retrieval in citrate buffer (pH 6.0) may improve detection .

  • Antibody dilution: Starting with 1:50-1:200 is recommended, with overnight incubation at 4°C for optimal results .

  • Controls to include:

    • Secondary antibody only (for background assessment)

    • Peptide competition controls

    • Comparative staining with H4K16ac antibodies to assess distribution differences

  • Colocalization analysis: Co-staining with markers of heterochromatin (H3K9me3) or euchromatin (H3K4me3) can provide context for the nuclear distribution pattern of propionylated H4K16 .

  • Quantification approaches: When comparing signal intensities between conditions, standardize image acquisition parameters and use software that allows for nuclear segmentation and intensity measurement .

Remember that nuclear distribution patterns may vary with cell type, cell cycle stage, and treatment conditions, necessitating careful experimental design and interpretation.

What are common issues when using Propionyl-HIST1H4A (K16) antibody and how can they be resolved?

Several common challenges may arise when using Propionyl-HIST1H4A (K16) antibody:

IssuePossible CausesSolutions
Weak or no signalLow modification levels, epitope masking, antibody degradationIncrease antibody concentration, optimize antigen retrieval, verify antibody storage conditions
High backgroundInsufficient blocking, high antibody concentration, non-specific bindingIncrease blocking time/concentration, titrate antibody, include additional washes
Cross-reactivityAntibody recognizing similar modifications (e.g., acetylation)Validate specificity with peptide arrays, include peptide competition controls
Inconsistent resultsLot-to-lot antibody variation, changing experimental conditionsUse consistent antibody lots for projects, standardize protocols
Masked epitopeNeighboring modifications affecting antibody accessConsider using complementary techniques (mass spectrometry)

To systematically troubleshoot these issues, employ a step-by-step approach addressing each variable independently while maintaining consistent controls .

How can Propionyl-HIST1H4A (K16) antibody be integrated into multi-omics studies of epigenetic regulation?

Integrating Propionyl-HIST1H4A (K16) antibody into multi-omics approaches can provide comprehensive insights into epigenetic regulation:

  • ChIP-seq with RNA-seq integration: Correlate genomic locations of H4K16 propionylation with transcriptional output to identify genes potentially regulated by this modification .

  • Sequential ChIP (re-ChIP): Perform successive immunoprecipitations using antibodies against different modifications to identify genomic regions where H4K16 propionylation co-occurs with other marks .

  • CUT&RUN or CUT&Tag: These techniques offer higher resolution and lower background than traditional ChIP, and may be particularly valuable for detecting less abundant modifications like propionylation .

  • Mass spectrometry integration: Combine antibody-based enrichment with mass spectrometry to identify proteins associated with propionylated histones and quantify modification stoichiometry .

  • Metabolomics correlation: Integrate propionylation data with measurements of cellular propionyl-CoA levels to investigate metabolic-epigenetic connections .

  • Multi-modification ChIP-seq: Perform parallel ChIP-seq for various histone modifications (acetylation, methylation, propionylation) to create comprehensive epigenetic maps and identify modification patterns associated with specific genomic features or cellular states .

This integrated approach can reveal how propionylation coordinates with other epigenetic mechanisms to regulate chromatin structure and function in different biological contexts.

How does the choice of cell fixation method affect the detection of H4K16 propionylation?

The fixation method significantly impacts the detection of histone modifications including H4K16 propionylation:

  • Formaldehyde fixation (CrossChIP): Standard approach using 1% formaldehyde for 10 minutes creates protein-protein and protein-DNA crosslinks. This preserves chromatin architecture but may reduce accessibility of some epitopes, particularly if the modification affects protein interactions .

  • Native ChIP: Omitting crosslinking and using micrococcal nuclease to fragment chromatin preserves modifications but disrupts higher-order chromatin interactions and may not capture transiently associated proteins .

  • Methanol fixation for immunofluorescence: Provides good nuclear preservation and accessibility but can extract some nuclear proteins and may affect certain epitopes .

  • Glyoxal fixation: Alternative to formaldehyde that may preserve some epitopes better while minimizing epitope masking .

  • Dual fixation (DSP followed by formaldehyde): Can improve retention of protein complexes while maintaining structure .

Researchers should compare multiple fixation methods when characterizing a new antibody or studying a particular modification. Side-by-side comparison of different fixation protocols using immunofluorescence or ChIP-qPCR at known targets can identify the optimal approach for a specific experimental question .

What emerging technologies might enhance the study of H4K16 propionylation dynamics?

Several cutting-edge technologies hold promise for advancing our understanding of H4K16 propionylation:

  • Single-cell epigenomics: Techniques like single-cell CUT&Tag could reveal cell-to-cell variation in propionylation patterns within heterogeneous populations .

  • Live-cell imaging of histone modifications: Developing modification-specific intrabodies or FRET-based sensors could allow real-time tracking of propionylation dynamics .

  • CRISPR epigenome editing: Targeted recruitment of propionyl-transferases or depropionylases to specific genomic loci can help establish causality between propionylation and gene expression .

  • Engineered reader domains: Developing specific protein domains that recognize propionylated lysines could enable enrichment of modified peptides for proteomics or serve as detection reagents .

  • High-throughput antibody validation: Systematic characterization of antibody specificity using peptide arrays, recombinant modified histones, and knockout systems will improve the reliability of propionylation studies .

  • Combinatorial modification analysis: New computational and experimental approaches to analyze how propionylation interacts with other histone modifications could reveal more complex "modification signatures" associated with specific genomic elements or cellular states .

These technological advances will help unravel the specific roles of propionylation in chromatin biology and potentially reveal new therapeutic targets in diseases with epigenetic dysregulation.

How can researchers distinguish the functional consequences of H4K16 propionylation versus other acylation modifications?

Distinguishing the specific functions of H4K16 propionylation requires multiple complementary approaches:

  • Site-specific histone mutations: Generating K16R mutations in histone H4 prevents all modifications at this residue, while K16Q can mimic some aspects of acylation. Comparing phenotypes with wild-type cells can reveal functional importance .

  • Selective enzymatic manipulation: Identifying and modulating enzymes that specifically catalyze or remove propionylation versus other acylations (e.g., acetylation) can help distinguish their roles .

  • Reader protein identification: Affinity purification using propionylated versus acetylated histone peptides can identify proteins that specifically recognize each modification, providing clues to downstream effectors .

  • Metabolic manipulation: Altering cellular metabolism to specifically affect propionyl-CoA levels (e.g., through odd-chain fatty acid supplementation) can modulate propionylation levels independently of acetylation .

  • Temporal dynamics: Pulse-chase experiments tracking the kinetics of different modifications after stimuli can reveal sequential ordering and potential causal relationships .

  • Genomic location analysis: High-resolution mapping of different acylations across the genome can identify sites where propionylation occurs uniquely or co-occurs with other modifications, suggesting functional relationships .

By integrating these approaches, researchers can build a comprehensive understanding of how H4K16 propionylation contributes distinctly to chromatin regulation and cellular function compared to other acylation marks.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.